AGFB Agfa-Gevaert NV

Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market - regulated information

Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market - regulated information

                                       

November 14, 2024 – 7:45 a.m. CET

Regulated information

Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market

Mortsel, Belgium – November 14, 2024 – 7:45 a.m. CET

Agfa today announced a plan to adjust the cost base of its traditional film activities to the reality in the market. The company has the intention to thoroughly reorganize all aspects of the film-related activities, with the goal of achieving savings of 50 million euro by the end of 2027.

On November 14, the intention to reorganize the film-related business was presented to the social partners in Belgium at an Extraordinary Works Council meeting.

If the intended plan would be executed, this would impact up to 530 employees in Belgium. Blue-collar employees, white-collar employees as well as management positions would be affected. Its implementation would run over a three year period. Agfa intends to avoid as many forced redundancies as possible by using the natural outflow of staff and also by encouraging mutations and re-employment.

“While we are convinced that the proposed measures are necessary for the future of our company, we are also very aware that this message might cause anxiety and uncertainty among our employees. We will do our utmost to maintain a constructive social dialogue with the social partners involved and keep the period of uncertainty as short as possible,” said Pascal Juéry, CEO of the Agfa-Gevaert Group.

(end of message)

About Agfa-Gevaert

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds three divisions: Radiology Solutions, HealthCare IT and Digital Print & Chemicals. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2023, the Group realized a turnover of 1,150 million euro.

Contact:

Viviane Dictus

Director Corporate Communications

tel. 4

e-mail:

Attachment



EN
14/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agfa-Gevaert NV

Agfa-Gevaert NV: 1 director

A director at Agfa-Gevaert NV bought 80,000 shares at 0.681EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Agfa-Geveart: Material miss on Healthcare activities. ASML: Long-term guidance confirmed. CVC Capital Partners: Comfortably on track. DEME Group: Raises outlook, lowers capex guidance. Proximus: Pressure on CEO from another possible coalition party. SBM Offshore: Again delivering

Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Wim Lewi
Guy Sips
  • Guy Sips

Agfa 3Q24 below forecasts & €50m savings program to align the cost bas...

3Q24 numbers were below our and CSS forecasts. We will update our model but we already lower our Target Price from € 2.0 to € 1.4. 3Q24 sales came in at € 277m (KBCSe € 291, CSS 286) and 3Q24 REBIT was €4m (KBCSe € 8.1m, CSS € 7m) with especially a poor performance in Radiology Solutions. Agfa hinted at a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. Thi...

 PRESS RELEASE

The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 1...

The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro - regulated information                                         Regulated information November 14, 2024 - 7:45 a.m. CET        The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro The Agfa-Gevaert Group posted double-digit revenue growth and a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. This was counterbalanced by an accelerated m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch